Cargando…
Effects of reduced β(2)-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice
BACKGROUND: Reduced β(2)-glycoprotein I (reduced β(2)GP I), which has free sulfhydryl groups, is present in plasma and serum; it can protect vascular endothelial cells from damage due to oxidative stress in vitro. We investigated the effects of reduced β(2)GP I on the expression of various matrix me...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166470/ https://www.ncbi.nlm.nih.gov/pubmed/25204377 http://dx.doi.org/10.1186/1471-2261-14-114 |
_version_ | 1782335279315550208 |
---|---|
author | Xu, Jun Wang, Penghua Wang, Tong Wang, Meijun Chen, Sisi Yu, Pei Yu, Demin |
author_facet | Xu, Jun Wang, Penghua Wang, Tong Wang, Meijun Chen, Sisi Yu, Pei Yu, Demin |
author_sort | Xu, Jun |
collection | PubMed |
description | BACKGROUND: Reduced β(2)-glycoprotein I (reduced β(2)GP I), which has free sulfhydryl groups, is present in plasma and serum; it can protect vascular endothelial cells from damage due to oxidative stress in vitro. We investigated the effects of reduced β(2)GP I on the expression of various matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) in the aortas of diabetic mice. METHODS: We provided 120 female 8-week-old Balb/c mice with a high sugar, high fat diet. After 8 weeks they were injected with streptozotocin to induce diabetes. We treated mice in the mono dose groups with β(2)GP I, reduced β(2)GP I, or phosphate-buffered saline (PBS) on day 1 and fed them for 3 weeks. The mice in the complex dose groups were treated with β(2)GP I, reduced β(2)GP I, or PBS on days 1 and 22 and fed for 6 weeks. Control mice were given a standard chow diet. Blood lipids were measured at the end of 3 or 6 weeks, and aortas removed to observe morphological and molecular biological changes. RESULTS: The low-density lipoprotein cholesterol levels in mice of the reduced β(2)GP I group were lower than those in the diabetic group. Aortic lipid deposition in the reduced β(2)GP I group was significantly less than in the diabetic control group. In the aortas, reduced β(2)GP I decreased MMP2/TIMP2 mRNA and protein expression levels, and MMP9/TIMP1 expression levels compared with those in diabetic controls. Reduced β(2)GP I down-regulated p38 mitogen-activated protein kinase (p38MAPK) mRNA expression and phosphorylated p38MAPK protein expression compared with those in diabetic controls of the complex dose group. CONCLUSIONS: Reduced β(2)GP I plays a role in diabetic mice related to vascular protection, inhibiting vascular lipid deposition, and plaque formation by reducing MMPs/TIMPs expression through down-regulation of the p38MAPK signaling pathway. |
format | Online Article Text |
id | pubmed-4166470 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41664702014-09-19 Effects of reduced β(2)-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice Xu, Jun Wang, Penghua Wang, Tong Wang, Meijun Chen, Sisi Yu, Pei Yu, Demin BMC Cardiovasc Disord Research Article BACKGROUND: Reduced β(2)-glycoprotein I (reduced β(2)GP I), which has free sulfhydryl groups, is present in plasma and serum; it can protect vascular endothelial cells from damage due to oxidative stress in vitro. We investigated the effects of reduced β(2)GP I on the expression of various matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) in the aortas of diabetic mice. METHODS: We provided 120 female 8-week-old Balb/c mice with a high sugar, high fat diet. After 8 weeks they were injected with streptozotocin to induce diabetes. We treated mice in the mono dose groups with β(2)GP I, reduced β(2)GP I, or phosphate-buffered saline (PBS) on day 1 and fed them for 3 weeks. The mice in the complex dose groups were treated with β(2)GP I, reduced β(2)GP I, or PBS on days 1 and 22 and fed for 6 weeks. Control mice were given a standard chow diet. Blood lipids were measured at the end of 3 or 6 weeks, and aortas removed to observe morphological and molecular biological changes. RESULTS: The low-density lipoprotein cholesterol levels in mice of the reduced β(2)GP I group were lower than those in the diabetic group. Aortic lipid deposition in the reduced β(2)GP I group was significantly less than in the diabetic control group. In the aortas, reduced β(2)GP I decreased MMP2/TIMP2 mRNA and protein expression levels, and MMP9/TIMP1 expression levels compared with those in diabetic controls. Reduced β(2)GP I down-regulated p38 mitogen-activated protein kinase (p38MAPK) mRNA expression and phosphorylated p38MAPK protein expression compared with those in diabetic controls of the complex dose group. CONCLUSIONS: Reduced β(2)GP I plays a role in diabetic mice related to vascular protection, inhibiting vascular lipid deposition, and plaque formation by reducing MMPs/TIMPs expression through down-regulation of the p38MAPK signaling pathway. BioMed Central 2014-09-10 /pmc/articles/PMC4166470/ /pubmed/25204377 http://dx.doi.org/10.1186/1471-2261-14-114 Text en © Xu et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Xu, Jun Wang, Penghua Wang, Tong Wang, Meijun Chen, Sisi Yu, Pei Yu, Demin Effects of reduced β(2)-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice |
title | Effects of reduced β(2)-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice |
title_full | Effects of reduced β(2)-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice |
title_fullStr | Effects of reduced β(2)-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice |
title_full_unstemmed | Effects of reduced β(2)-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice |
title_short | Effects of reduced β(2)-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice |
title_sort | effects of reduced β(2)-glycoprotein i on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166470/ https://www.ncbi.nlm.nih.gov/pubmed/25204377 http://dx.doi.org/10.1186/1471-2261-14-114 |
work_keys_str_mv | AT xujun effectsofreducedb2glycoproteiniontheexpressionofaorticmatrixmetalloproteinasesandtissueinhibitormatrixmetalloproteinasesindiabeticmice AT wangpenghua effectsofreducedb2glycoproteiniontheexpressionofaorticmatrixmetalloproteinasesandtissueinhibitormatrixmetalloproteinasesindiabeticmice AT wangtong effectsofreducedb2glycoproteiniontheexpressionofaorticmatrixmetalloproteinasesandtissueinhibitormatrixmetalloproteinasesindiabeticmice AT wangmeijun effectsofreducedb2glycoproteiniontheexpressionofaorticmatrixmetalloproteinasesandtissueinhibitormatrixmetalloproteinasesindiabeticmice AT chensisi effectsofreducedb2glycoproteiniontheexpressionofaorticmatrixmetalloproteinasesandtissueinhibitormatrixmetalloproteinasesindiabeticmice AT yupei effectsofreducedb2glycoproteiniontheexpressionofaorticmatrixmetalloproteinasesandtissueinhibitormatrixmetalloproteinasesindiabeticmice AT yudemin effectsofreducedb2glycoproteiniontheexpressionofaorticmatrixmetalloproteinasesandtissueinhibitormatrixmetalloproteinasesindiabeticmice |